Investors

Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)

Announcements

Opyl appoints Dr Megan Robertson to its Board

download

Opyl completes oversubscribed share purchase plan

download

Clinical trial recruitment platform achieves first major milestone

download

Opyl completes unmarketable parcel share buy-back

download

Opyl Implements Unmarketable Parcel Share Sale Facility

download

Opyl H1 FY 2021

download

See all Announcements

Presentations

Opyl – Half Year Investor Presentation

download

AGM 2020 Presentation

download

Investor Update – June 2019

download

Investor Update – Oct 2019

download

AGM Investor Update – Nov 2019

download

Quarterly Reports

Opyl Appendix 4C – Quarter (Q3) ending 31 March 2021

download

Opyl Appendix 4C – Quarter (Q1) ending 30 September 2020

download

Q4 Report and Appendix 4C 2020

download

Q3 Report and Appendix 4C 2020

download

Q2 Report and Appendix 4C 2020

download

See all Queartly Reports

Annual Reports

Opyl 2020 Annual Report

download

SRO Annual Report 2019

download

Governance

Share Purchase Plan Offer Booklet

download

Opyl – 2020 Corporate Governance Statement

download

Opyl – Audit and Risk Committee Charter 2020

download

Opyl – Board Charter 2020

download

Opyl – Code of Conduct (New) 2020

download

Opyl – Diversity Policy 2020

download

Opyl – Remuneration and Nomination Committee Charter 2020

download

Opyl – Trading Policy (New) 2020

download

Opyl – Whistleblower (New) 2020

download

Opyl Disclosure and Communication Policy Update 2020

download

News

Radical rebirth for Opyl as focus switches from user-generated content to health and life sciences

download

Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)

Announcements

Opyl appoints Dr Megan Robertson to its Board

Opyl completes oversubscribed share purchase plan

Clinical trial recruitment platform achieves first major milestone

Opyl completes unmarketable parcel share buy-back

Opyl Implements Unmarketable Parcel Share Sale Facility

Opyl H1 FY 2021

Presentations

Opyl – Half Year Investor Presentation

AGM 2020 Presentation

Investor Update – June 2019

Investor Update – Oct 2019

AGM Investor Update – Nov 2019

Quarterly Reports

Opyl Appendix 4C – Quarter (Q3) ending 31 March 2021

Opyl Appendix 4C – Quarter (Q1) ending 30 September 2020

Q4 Report and Appendix 4C 2020

Q3 Report and Appendix 4C 2020

Q2 Report and Appendix 4C 2020

Annual Reports

Opyl 2020 Annual Report

SRO Annual Report 2019

Governance

Share Purchase Plan Offer Booklet

Opyl – 2020 Corporate Governance Statement

Opyl – Audit and Risk Committee Charter 2020

Opyl – Board Charter 2020

Opyl – Code of Conduct (New) 2020

Opyl – Diversity Policy 2020

Opyl – Remuneration and Nomination Committee Charter 2020

Opyl – Trading Policy (New) 2020

Opyl – Whistleblower (New) 2020

Opyl Disclosure and Communication Policy Update 2020

News

Radical rebirth for Opyl as focus switches from user-generated content to health and life sciences

Share Registry

Automic Share Registry
1300 288 664

Investors

Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)

Announcements

Opyl appoints Dr Megan Robertson to its Board

Opyl completes oversubscribed share purchase plan

Clinical trial recruitment platform achieves first major milestone

Opyl completes unmarketable parcel share buy-back

Opyl Implements Unmarketable Parcel Share Sale Facility

Opyl H1 FY 2021

Presentations

Opyl – Half Year Investor Presentation

AGM 2020 Presentation

Investor Update – June 2019

Investor Update – Oct 2019

AGM Investor Update – Nov 2019

Quarterly Reports

Opyl Appendix 4C – Quarter (Q3) ending 31 March 2021

Opyl Appendix 4C – Quarter (Q1) ending 30 September 2020

Q4 Report and Appendix 4C 2020

Q3 Report and Appendix 4C 2020

Q2 Report and Appendix 4C 2020

Annual Reports

Opyl 2020 Annual Report

SRO Annual Report 2019

Governance

Share Purchase Plan Offer Booklet

Opyl – 2020 Corporate Governance Statement

Opyl – Audit and Risk Committee Charter 2020

Opyl – Board Charter 2020

Opyl – Code of Conduct (New) 2020

Opyl – Diversity Policy 2020

Opyl – Remuneration and Nomination Committee Charter 2020

Opyl – Trading Policy (New) 2020

Opyl – Whistleblower (New) 2020

Opyl Disclosure and Communication Policy Update 2020

News

Radical rebirth for Opyl as focus switches from user-generated content to health and life sciences

Share Registry

Automic Share Registry1300 288 664

Automic Share Registry
1300 288 664